According to Merrimack Pharmaceuticals's latest financial reports the company's current earnings (TTM) are -HK$17.61 M. In 2023 the company made an earning of -HK$16.97 M a decrease over its 2022 earnings that were of -HK$16.95 M.The earnings displayed on this page is the company's Pretax Income.